Govt Amends NDCT Rules to Cut Drug Approval Timelines

30 Jan 2026 CW Team

The Union Ministry of Health and Family Welfare has recently notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, aimed at reducing regulatory burden and improving Ease of Doing Business in the pharmaceutical sector. The changes focus on simplifying approval processes and significantly shortening timelines for drug development and clinical research.

Under the revised framework, the requirement for pharmaceutical companies to obtain a test licence from the Central Drugs Standard Control Organization (CDSCO) for non-commercial manufacture of small quantities of drugs for research or analysis has been replaced with a prior-intimation system. Companies may now proceed after submitting an online intimation, except for a limited category of high-risk drugs such as cytotoxic, narcotic and psychotropic substances. This move is expected to save at least 90 days in the drug development cycle.

For categories where test licences continue to apply, the statutory processing timeline has been reduced from 90 days to 45 days. With CDSCO handling nearly 30,000–35,000 such applications annually, the reform is expected to substantially ease compliance requirements for the industry.

In another major change, prior approval for certain low-risk Bioavailability and Bioequivalence (BA/BE) studies has been waived. These studies can now commence based on a simple online intimation, benefiting the generic pharmaceutical segment. CDSCO processes around 4,000–4,500 BA/BE applications each year.

Dedicated online modules on the National Single Window System and the SUGAM portal will support seamless implementation. Overall, the reforms are expected to accelerate research, optimise regulatory resources, and strengthen India’s position as a global hub for pharmaceutical R&D.

Infrastructure Urban

20 Mar 2026

Lemon Tree Hotels Signs Resort In Lonavala Maharashtra

Lemon Tree Hotels Limited (LTHL) has signed a licence agreement for Lemon Tree Resort in Lonavala, Maharashtra, with the asset to be managed by Carnation Hotels Private Limited, a wholly owned subsidiary of LTHL. The resort will offer 50 well appointed rooms and will include a restaurant, banquet, meeting room, swimming pool, spa and fitness centre. The company described the addition as part of its strategy to expand branded resort offerings in key getaway destinations. Lonavala, located in the Sahyadri hills, is a popular leisure destination in western India known for scenic landscapes and a ..

Kalai Chettinad Art And Architecture Festival At The Lotus Palace

The Lotus Palace Chettinad will host Kalai, the Chettinad Art and Architecture Festival, a four-day, three-night immersive celebration of the artistic legacy of Chettinad from three to six April 2026. The event has been organised by Apeejay Surrendra Park Hotels Limited (ASPHL) and will take place across restored heritage properties in Chettinad. It will be designed to offer guests a layered experience of place, structure and story that connects art, architecture and living traditions. The festival aims to present a confluence of global influences and local aesthetics. Kalai has been curated i..

SJVN Reaches One bn Units At 1,000 MW Bikaner Solar Project

SJVN Limited (SJVN) has reached a milestone with its 1,000 megawatt (MW) Bikaner Solar Power Project by generating one bn units of electricity on 20 March 2026. The achievement underscores the company's role in supplying clean and sustainable energy to the national grid. The generation milestone was recorded within months of the project commencing operations and highlights rapid performance from the new facility. The Bikaner project, located in Bikaner district of Rajasthan, has been developed and implemented by SJVN Green Energy Limited (SGEL) under the Central Public Sector Undertaking Schem..